T1	Participants 126 182	patients with hepatic metastases from colorectal cancer:
T2	Participants 265 451	74 patients with hepatic metastases from colorectal cancer were randomized to either intra-arterial hepatic artery infusion with 5-fluorouracil (5-FU) or systemic chemotherapy with 5-FU.
T3	Participants 1219 1252	patients with hepatic metastases.
